Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response

Jessica B. Foster*, Namrata Choudhari, Jessica Perazzelli, Julie Storm, Ted J. Hofmann, Payal Jain, Phillip B. Storm, Norbert Pardi, Drew Weissman, Angela Jae Waanders, Stephan A. Grupp, Katalin Karikó, Adam C. Resnick, David M. Barrett

*Corresponding author for this work

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

T cells made with messenger RNA (mRNA) encoding chimeric antigen receptor (CAR) offer a safe alternative to those transduced with viral CARs by mitigating the side effects of constitutively active T cells. Previous studies have shown that mRNA CAR T cells are transiently effective but lack persistence and potency across tumor types. It was hypothesized that the efficacy of mRNA CARs could be improved by utilizing recent advancements in RNA technology, such as incorporating a modified nucleoside, 1-methylpseudouridine, into the mRNA and applying a novel purification method using RNase III to eliminate dsRNA contaminants. T cells electroporated with nucleoside-modified and purified mRNA encoding CD19 CAR showed an initial twofold increase in CAR surface expression, as well as a twofold improvement in cytotoxic killing of leukemia cells that persisted up to 5 days. T cells generated with nucleoside-modified and purified CAR mRNA also showed reduced expression of checkpoint regulators and a differential pattern of genetic activation compared to those made with conventional mRNA. In vivo studies using a leukemia mouse model revealed that the most robust 100-fold suppression of leukemic burden was achieved using T cells electroporated with purified mRNAs, regardless of their nucleoside modification. The results provide a novel approach to generate mRNA for clinical trials, and poise mRNA CAR T cells for increased efficacy during testing as new CAR targets emerge.

Original languageEnglish (US)
Pages (from-to)168-178
Number of pages11
JournalHuman Gene Therapy
Volume30
Issue number2
DOIs
StatePublished - Feb 2019

Keywords

  • RNA
  • T cell
  • chimeric antigen receptor
  • immunotherapy

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Fingerprint Dive into the research topics of 'Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response'. Together they form a unique fingerprint.

  • Cite this

    Foster, J. B., Choudhari, N., Perazzelli, J., Storm, J., Hofmann, T. J., Jain, P., Storm, P. B., Pardi, N., Weissman, D., Waanders, A. J., Grupp, S. A., Karikó, K., Resnick, A. C., & Barrett, D. M. (2019). Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response. Human Gene Therapy, 30(2), 168-178. https://doi.org/10.1089/hum.2018.145